Form 3 Filing for Ascentage Pharma Group International

This filing details restricted stock units (RSUs) granted to Jin Cao, Chief Accounting Officer of Ascentage Pharma Group International. Each RSU represents a contingent right to one Ordinary Share, vesting in four equal increments on November 26th of 2026, 2027, 2028, and 2029. The filing also includes a Power of Attorney, authorizing Thomas J. Knapp and Leslie Brault to act on behalf of Jin Cao for all SEC filings, including Forms 3, 4, and 5, and other necessary documentation. This authorization covers EDGAR system submissions and information gathering regarding the company's equity securities. The Power of Attorney remains effective until Jin Cao is no longer required to file these forms.